Major Thromboembolic and Hemorrhagic Complications Occurring Within 30 Days After AVR in Group 1 and Group 2 Patients
| Variable | Group 1 | Group 2 |
|---|---|---|
| % (no. of events) | % (no. of events) | |
| Cerebrovascular accident | ||
| Reversible thromboembolism | 0.26 (1) | — |
| Major nonfatal thromboembolism | 0.52 (2) | 2.33 (5) |
| Major fatal thromboembolism | — | 0.93 (2) |
| Systemic major thromboembolism | 0.26 (1) | 0.47 (1) |
| Thrombosis | — | — |
| Nonfatal hemorrhage | — | 0.93 (2) |